Intellia Therapeutics Inc buy Oppenheimer Holdings Inc.
Start price
11.11.24
/
50%
€16.19
Target price
11.11.25
€56.29
Performance (%)
-46.53%
End price
12.11.25
€8.66
Summary
This prediction ended on 12.11.25 with a price of €8.66. Massive losses of -46.53% were the result for the BUY prediction by Oppenheimer_Holdings. Oppenheimer_Holdings has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 14.863% | 14.863% | 14.016% |
| iShares Core DAX® | -1.764% | 2.259% | 15.213% |
| iShares Nasdaq 100 | -1.632% | -0.193% | 3.293% |
| iShares Nikkei 225® | -2.451% | 4.086% | 17.198% |
| iShares S&P 500 | -2.252% | -0.151% | 0.574% |
Comments by Oppenheimer_Holdings for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Oppenheimer Holdings Inc. from $70.00 to $60.00. They now have an "outperform" rating on the stock.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von Oppenheimer_Holdings gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Oppenheimer_Holdings for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.72
13.01.25
13.01.25
€39.21
13.01.26
13.01.26
4.78%
14.01.26
14.01.26
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€22.25
13.11.23
13.11.23
€65.39
13.11.24
13.11.24
-30.31%
14.11.24
14.11.24